Sitagliptin (MK-0431) for Type 2 Diabetes shows promise in Phase II clinical trials
Sat, 11 Jun 2005 03:00 PM EST
... Results from three Phase II studies announced today, show that sitagliptin phosphate (MK-0431) was efficacious and well tolerated in patients with type 2 diabetes... click link for more info. ...
Related Topics
- Clinical Trials
- Juvenile Diabetes
- Diabetes - Type 1
- Diabetes - Type 2
- Diabetes and Pregnancy
- Diabetes
- Diabetes Insipidus
- Mucopolysaccharidosis
- Kniest dysplasia
- Gestational Diabetes
- Insulin
- Pharmacology
- Cockayne Syndrome Type II
- Psychopharmacology
- Ramsay Hunt Syndrome Type II
- Herpes Simplex
- Neurofibromatosis
- Epidemiology
- Type 1 diabetes
- Type 2 diabetes

Not Signed In -


